FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial

FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial

Abstract Background Fimasartan is the ninth angiotensin receptor blocker to be developed. However, it has not yet been evaluated for reno-protective effects in hypertensive diabetic chronic kidney disease (CKD). The target blood pressure (BP) for hypertensive diabetic CKD is also a controversial top...

Full description

Bibliographic Details
Main Authors: Jang-Young Kim, Jung-Woo Son, Sungha Park, Tea-Hyun Yoo, Yong-Jin Kim, Dong-Ryeol Ryu, Ho Jun Chin
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Trials
Subjects:
Proteinuria
Chronic kidney disease
Hypertension
Diabetes mellitus
Online Access:http://link.springer.com/article/10.1186/s13063-017-2375-8

Internet

http://link.springer.com/article/10.1186/s13063-017-2375-8

Similar Items